# TASK A20: IN VITRO SCREENING FOR ANTIFUNGAL ACTIVITY AGAINST FUNGAL DISEASE PATHOGENS

> **NIH NIH N01** · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · 2022 · $66,048

## Abstract

This contract provides in vitro testing of potential anti-bacterial and anti-fungal agents, maintenance of bacterial and fungal stocks, and the development of related assays.

## Key facts

- **NIH application ID:** 10704917
- **Project number:** 75N93019D00022-0-759302200001-1
- **Recipient organization:** UNIVERSITY OF TEXAS HLTH SCIENCE CENTER
- **Principal Investigator:** THOMAS PATTERSON
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $66,048
- **Award type:** —
- **Project period:** 2022-04-28 → 2023-04-27

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10704917

## Citation

> US National Institutes of Health, RePORTER application 10704917, TASK A20: IN VITRO SCREENING FOR ANTIFUNGAL ACTIVITY AGAINST FUNGAL DISEASE PATHOGENS (75N93019D00022-0-759302200001-1). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/10704917. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*